BridgeMD
New treatment option for Myocardial Infarction
Official title Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
ClinicalTrials.gov ID: NCT05925634
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare two types of exercise prescriptions in cardiac rehabilitation eligible older adults (60 years or older) with heart disease. The investigators found in a single site pilot trial (insert NCTxxx) that one exercise prescription was better and are now repeating this study in a larger population at two sites (Baystate Medical Center, Springfield MA and Henry Ford Health System, Detroit MI).
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 99
You may be able to join if
- Patients who are eligible for cardiac rehabilitation by having had a cardiac event such as a myocardial infarction (heart attack), heart failure...
- Lives in, or plans to reside in, the Springfield, MA, or greater Detroit, MI, area for the next year.
- Recruited from a Phase 2 Cardiac Rehabilitation Center at either Baystate Medical Center or Henry Ford Health System.
- Age ≥ 60 years
- Agrees to attend at least 18 sessions of cardiac rehabilitation after randomization
You likely can't join if
- These include conditions that alter the physiology and monitoring of resting and exercise heart rate. These also include conditions that might limit...
- Permanent atrial fibrillation
- Heart transplant
- Left-ventricular assist devices
- Stable angina
- High-risk un-revascularized coronary artery disease
See the full eligibility criteria
- Patients who are eligible for cardiac rehabilitation by having had a cardiac event such as a myocardial infarction (heart attack), heart failure, percutaneous coronary intervention or angioplasty with stent, coronary...
- Lives in, or plans to reside in, the Springfield, MA, or greater Detroit, MI, area for the next year.
- Recruited from a Phase 2 Cardiac Rehabilitation Center at either Baystate Medical Center or Henry Ford Health System.
- Age ≥ 60 years
- Agrees to attend at least 18 sessions of cardiac rehabilitation after randomization
- Agrees to attend cardiac rehabilitation at least twice a week
- These include conditions that alter the physiology and monitoring of resting and exercise heart rate. These also include conditions that might limit an individual's ability to exercise.
- Permanent atrial fibrillation
- Heart transplant
- Left-ventricular assist devices
- Stable angina
- High-risk un-revascularized coronary artery disease
- Symptomatic peripheral artery disease
- Aortic and/or mitral stenosis
- Any condition where exercise testing or training might be unsafe or limited
The study team makes the final eligibility decision.
Where it's taking place
- Springfield, Massachusetts, United States
- Detroit, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Springfield, Massachusetts, United States; Detroit, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.